Welcome to LookChem.com Sign In|Join Free

CAS

  • or

121253-53-0

Post Buying Request

121253-53-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

121253-53-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 121253-53-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,2,5 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 121253-53:
(8*1)+(7*2)+(6*1)+(5*2)+(4*5)+(3*3)+(2*5)+(1*3)=80
80 % 10 = 0
So 121253-53-0 is a valid CAS Registry Number.

121253-53-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-ethoxy-5-phenyl-4-[[(phenylmethoxy)carbonyl]amino]-3-oxo-1-pentene

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:121253-53-0 SDS

121253-53-0Relevant articles and documents

HIV protease inhibitors

-

Page/Page column 21, (2010/02/11)

Combinatorial libraries of HIV and FIV protease inhibitors are characterized by alpha-keto amide or hydroxyethylamine core structures flanked by on one side by substituted pyrrolidines, piperidines, or azasugars and on the other side by phenylalanine, tyrosine, or substituted tyrosines. The libraries are synthesized via a one step coupling reaction. Highly efficacious drug candidates are identified by screening the libraries for binding and inhibitory activity against both HIV and FIV protease. Drug candidates displaying clinically useful activity against both HIV and FIV protease are identified as being potentially resistive against a loss of inhibitory activity due to development of resistant strains of HIV.

An Efficient Synthesis of Novel α-Diketone and α-Keto Ester Derivatives of N-Protected Amino Acids and Peptides

Angelastro, Michael R.,Peet, Norton P.,Bey, Philippe

, p. 3913 - 3916 (2007/10/02)

A novel synthetic approach to α-diketone and α-keto ester derivatives of N-protected amino acids and peptides via a common intermediate is described.Conversion of the carboxyl group of N-protected amino acids and peptides into an α-keto vinyl ether functi

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 121253-53-0